三季度规模增超百亿元！年内“冠军基”最新重仓股曝光

Core Insights - The recent quarterly reports from public funds indicate a significant increase in equity positions, reflecting fund managers' positive outlook on market opportunities [1][6][7] Group 1: Fund Performance - The "champion fund" Yongying Technology Smart Mixed Fund reported a total scale of 11.52 billion yuan, a remarkable increase of 888.09% from the previous quarter [4] - The fund's equity investment ratio rose to 91.59%, up from 86.38% in the previous quarter, indicating a strong bullish sentiment [4] - The top three holdings of the fund include Xinyi Technology, Zhongji Xuchuang, and Tianfu Communication, with respective market values of 1.125 billion yuan, 1.092 billion yuan, and 1.034 billion yuan [4] Group 2: Sector Focus - The Yongying Technology Smart Mixed Fund's manager highlighted the ongoing potential in the global cloud computing industry and the increasing value of AI models [5] - The Longcheng Pharmaceutical Industry Selected Mixed Fund also increased its equity investment ratio to 82.18%, focusing on innovative pharmaceutical stocks in the Hong Kong market [6] - The top three holdings of the Longcheng fund include Innovent Biologics, 3SBio, and Hotgen Biotech, with significant year-to-date gains [6] Group 3: Market Outlook - The technology sector, particularly cloud computing and artificial intelligence, is expected to benefit from accelerated digital transformation and strong market demand [7] - The innovative pharmaceutical sector in Hong Kong is poised for growth due to rising global healthcare demands and advancements in China's biopharmaceutical capabilities [7] - Both sectors are viewed as having broad investment windows, with potential for sustained value creation as technology progresses and consumer upgrades occur [7]